Cigna: Shares Marching To Full Recovery

Cigna Group is reiterated as a "Buy," driven by strong Q1 2026 results, raised guidance, and sustained business momentum. CI's pharmacy and behavioral health segments are fueling revenue growth, while divestitures and PBM reform temporarily temper 2026 earnings. Shares trade at a 25% discount to a $377 fair value estimate, offering potential 15% annual total returns through 2031.

Seeking Alpha • an hour ago

Here's Why Investors Should Hold On to Cigna Stock for Now

CI trades below the industry's forward P/E as Evernorth's growth, earnings beats and shareholder returns support its long-term outlook.

Zacks Investment Research • May 15, 2026

The Cigna Group (CI) Presents at Bank of America Global Healthcare Conference 2026 Transcript

The Cigna Group (CI) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • May 13, 2026

The Cigna Group Announces Appearance at the BofA Securities 2026 Health Care Conference

BLOOMFIELD, Conn., May 13, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced that Brian Evanko, President and Chief Operating Officer of The Cigna Group, will present at the BofA Securities 2026 Health Care Conference today, May 13, 2026, in Las Vegas, NV.

PRNewsWire • May 13, 2026

Easing medical costs a positive for health insurers, but real test lies ahead, analysts say

U.S. health insurers' strong first-quarter results signaled more stable medical costs after prolonged pressure, but Wall Street analysts want to see another similar quarter before they are convinced.

Reuters • May 13, 2026

Why Cigna (CI) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • May 12, 2026

Health Insurers Performing Better But There's Potential Trouble Ahead

Health insurance companies including UnitedHealthcare, CVS Health's Aetna, Centene and Blue Cross and Blue Shield plans owned by Elevance Health are seeing lower costs from patients submitting claims.

Forbes • May 10, 2026

Why Cigna (CI) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • May 7, 2026

Why Cigna (CI) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • May 6, 2026

Major health insurers show signs of recovery – but a key test looms

Solid first-quarter results from major insurers like UnitedHealth, Elevance, Cigna and Humana have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. But analysts caution that insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, which sets up the second quarter as the real proving ground.

CNBC • May 5, 2026